CPhI North America 2022: Philadelphia, 17-19 May
PharmaNutra will be one of the exhibitors at CPhI North America 2022, presenting new solutions and technologies for the nutraceutical and pharmaceutical sector to the American market.
Taking place from 17 to 19 May at the Pennsylvania Convention Center in Philadelphia, CPhI North America 2022 is one of the most important US events devoted to the pharmaceutical sector, with professionals and exhibitors from all segments of the supply chain: from research to raw materials manufacturing, from packaging and logistics to finished products. A unique opportunity to introduce the US market to SiderAL® and Cetilar® branded products, but above all the technologies developed and patented by the PharmaNutra Group.
Sucrosomial® Technology, the absorption mechanisms applied to iron and minerals already known in many countries in Europe, Asia and Latin America, can represent a significant innovation for the US nutraceutical industry, a highly competitive yet receptive market in which consumer attention is increasingly focused on healthier lifestyles, a correct diet and disease prevention.
Furthermore, for the first time, there will be an official presentation of Lipocet®, the novel food made with cetylated fatty acids (CFAs) authorised by the EC as a Novel Food and already recognised by the FDA as a GRAS (Generally Recognized As Safe) substance. Lipocet® is an innovative functional ingredient for oral use, designed for muscle and joint well-being and patented by PharmaNutra, which thanks to the efficacy of CFA-based formulations has developed and marketed products for topical use under the Cetilar® brand.
CPhI North America 2022 is a major opportunity for establishing useful contacts for developing the business in markets with huge potential like the United States and Canada. Trade fairs and events devoted to the pharmaceutical sector are fundamental not only for commercial but also scientific purposes, as they offer the chance to present clinical studies and evidence, coming into contact with the many institutions that invest and work in research.